(recurrent aphtosis, abdominal bloating and pain, diarrhoea and/or constipation, nausea and or vorrutmg, with endoscopic findings of chronic gastroduodenitis) and other aspecific systemic clinical manifestations including headache, chronic fatigue, post-prandial dyspnea, cystitis and/or vulvovaginitis, acne and iron deficiency anaemia.
These cutaneous and extra-cutaneous symptoms, when correlated to the ingestion of foods and beverages containing nickel, define the so-called "systemic nickel allergy syndrome" (SNAS) (6) . This clinical condition has been treated successfully with nickel oral hyposensitizing treatment (NiOH) (7) which has also proved to influence the nickelinduced immunologic response (8) .
The correct approach to the diagnosis of SNAS should mimic the natural exposure, thus should be supported by a positive oral provocation test with nickel-containing foods (such as vegetables) or with nickel-containing capsules, after obtaining a significant improvement with a low nickel diet (9) . Patients can be investigated for SNAS only if nickel sensitization is confirmed by a positive patch-test (10) .
Although some data concerning the correlation between the ingestion of foods containing nickel and the onset of cutaneous and gastrointestinal symptoms have been previously reported (11-14), the available information is insufficient to draw definitive conclusions about the epidemiology of SNAS. For this reason we conducted a crosssectional study aimed at determining the prevalence of SNAS among the population of patients afferent to four allergy units in Sicily, also reporting the most common symptoms of SNAS presentation and the most common triggering foods.
MATERIALS AND METHODS

Patients
Our study included 1,696 consecutive patients afferent to four allergy units in Sicily, a region of southern Italy, between October 20 I0 and March 20 II. All of them had been referred by their General Practitioners (GPs) for allergological evaluation and allergy tests if needed.
Written informed consent was obtained from all subjects enrolled in the study.
Methods
Following the collection of clinical history and (Table I) , of the previously mentioned symptoms. To confirm the diagnosis of SNAS, the patients also underwent an oral provocation test (OPT) with nickel sulphate capsules (Lofarma S.p.A., Milano, Italy) in an open challenge fashion. The maximum cumulative dose of 3.75 mg of nickel sulphate was chosen on the basis of previous studies showing that this amount is approximately 10 times greater than the estimated normal daily dietary intake of nickel and therefore it is expected to cause flare-up reactions in most of nickel-sensitive individuals (13) . Nickel sulphate was given at the dose of 1.25 mg the first day. In absence of symptoms two further single doses of I .25 mg were given on the second day.
The skin status and the global clinical condition were evaluated and recorded 24 h after the challenge. A positive response was defined as the occurrence of cutaneous eruptions of previously unaffected skin, flare-up at previous sites of ACD (including the flare-up reactions of previously positive patch test sites), urticaria and/or angioedema and any other systemic manifestation, such as headache, marked fatigue and gastrointestinal symptoms (heartburn and abdominal distension, abdominal pain, diarrhoea and/or constipation, nausea and/or vomiting).
Statistics
Data are reported as mean ± SO. Differences between categorical groups were analyzed by the Pearson Chisquare (c') test. In the statistical analyses the level of significance was set at P=0.05.
RESULTS
A total of I,696 patients (mean age: 31.21±12.45; 1,123 females and 573 males) afferent to four allergy units were included in the study; 697 patients (41.10% of total) were affected by rhinoconjunctivitis, 272 (16.04%) by asthma, 109 Some allergic co-morbidities could be found in subjects with SNAS: 37 subjects (37.8%) also had allergic rhinoconjunctivitis, 10 (10.2%) had allergic asthma and 16 (16.3%) were diagnosed with an IgEmediated food allergy (with positive history and skin tests) with a statistically significant association to SNAS (X2=16.950; P<O.OOOI).
SNAS correlated symptoms are reported in Table II , triggered by a quite wide range of foods (Table III) . Gastro-enteric symptoms like meteorism and bloating were very commonly correlated to SNAS, followed by flare-up of ACD, headache, heartburn, recurrent abdominal pain, urticaria and/or angioedema, while diarrhoea, constipation, and SCD occurred less frequently. Few patients complained of migraine, rosacea, acne, iron deficiency anaemia.
Legumes and tomatoes were the most common triggering foods, followed by cocoa and some vegetables like lettuce, broccoli, cauliflower and onions. The intensity of nickel patch test reactions in these patients was "+" in 4 subjects, "++" in 58 and "+++" in 36 but the grade of reactivity to nickel patch-test did not correlate to the intensity of SNAS symptoms. In some patients a concomitant positivity to other haptens, especially to cobalt chloride (16 patients), was found.
DISCUSSION
Although numerous studies document the prevalence of ACD to nickel, to our knowledge no epidemiological study so far has addressed the issue of estimating SNAS incidence. In our study, SNAS was diagnosed in 98 patients out of 1,696; the prevalence of SNAS in our sample was calculated as being around 5.78%, mostly women.
The main SNAS symptoms reported by our patients were gastrointestinal and cutaneous, apart from headache, and SCD which was present in 15.3% of patients; a similar incidence of nickel-induced SCD was reported to occur in 10% of patients consuming food with high nickel content (IS).
The high prevalence of gastrointestinal symptoms in our SNAS population is supported by the findings of Di Gioacchino et al. (16) who observed a marked inflammatory infiltrate, mainly lymphoplasmacellular, associated to duodenum villus deformation and deepening of the crypta, in patients with nickel related ACD after an oral nickel challenge. Similarly, Cazzato et al. documented a nickel-related pro-inflammatory status at the intestinal mucosa in SNAS patients (17) . The alteration of the intestinal barrier functions with an increased dietary antigen transportation, as well as exposure of dietary antigens to the mucosal immune system, may lead to the development of the dietary antigen-specific response (18) and could explain the high incidence of FA found in our SNAS patients.
Although the nickel content in individual foods can vary widely, a number of foods has been recognized as particularly rich in this metal, including peanuts, beans, lentils, peas, soybeans, oats, cocoa, chocolate, nuts, whole wheat, pears and mushrooms (19) . Our study confirmed that fresh and dried legumes represent the most common foods triggering SNAS, followed by tomatoes, cocoa and nuts. Soy and oatmeal were rarely reported to cause symptoms, probably because ofthe low consumption of these foods in our region.
In conclusion, our data support the role of nickelcontaining foods as potentially responsible for cutaneous and extra-cutaneous symptoms in nickel sensitized patients. These patients can be diagnosed with SNAS after a positive nickel patch-test result, symptom improvement following a low nickel diet and a positive result to a nickel OPT.
